Bio-Rad Laboratories (BIO) Q3 2024 Earnings
BIO·Reported October 30, 2024·After market close
Bio-Rad Laboratories reported Q3 2024 revenue of $649.7M, missed analyst consensus of $681.3M by $31.6M. Diluted EPS came in at $2.01, beat the $1.28 consensus by $0.73.
Revenue
$649.7Mmissed by $31.6M
Consensus: $681.3MDiluted EPS
$2.01beat by $0.73
Consensus: $1.28
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Bio-Rad Laboratories's Q3 2024 earnings report.
Bio-Rad Laboratories (BIO) reported Q3 2024 earnings on October 30, 2024 after market close.
Bio-Rad Laboratories reported revenue of $649.7M and diluted EPS of $2.01 for Q3 2024.
Revenue missed the consensus estimate of $681.3M by $31.6M. EPS beat the consensus estimate of $1.28 by $0.73.
You can read the 10-Q periodic report (0000012208-24-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.